Spironolactone Ceva

RSS

Withdrawn

This medicine's authorisation has been withdrawn

spironolactone
MedicineVeterinaryWithdrawn

Estonian is available via eTranslation, the European Commission's machine translation service.

Translate to Estonian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for this product has been withdrawn due to the application of the sunset clause.

български (BG) (332.91 KB - PDF)

Vaata

español (ES) (288.28 KB - PDF)

Vaata

čeština (CS) (322.23 KB - PDF)

Vaata

dansk (DA) (287.53 KB - PDF)

Vaata

Deutsch (DE) (289.53 KB - PDF)

Vaata

eesti (ET) (276.29 KB - PDF)

Vaata

ελληνικά (EL) (335.21 KB - PDF)

Vaata

français (FR) (289.25 KB - PDF)

Vaata

hrvatski (HR) (307.68 KB - PDF)

Vaata

latviešu (LV) (334.28 KB - PDF)

Vaata

Malti (MT) (324.47 KB - PDF)

Vaata

Nederlands (NL) (287.82 KB - PDF)

Vaata

polski (PL) (380.69 KB - PDF)

Vaata

português (PT) (288.12 KB - PDF)

Vaata

română (RO) (482.45 KB - PDF)

Vaata

slovenčina (SK) (324.97 KB - PDF)

Vaata

slovenščina (SL) (318.42 KB - PDF)

Vaata

suomi (FI) (285.73 KB - PDF)

Vaata

svenska (SV) (287.15 KB - PDF)

Vaata

Product information

български (BG) (936.84 KB - PDF)

Vaata

español (ES) (457.64 KB - PDF)

Vaata

čeština (CS) (695.23 KB - PDF)

Vaata

dansk (DA) (443.55 KB - PDF)

Vaata

Deutsch (DE) (456.17 KB - PDF)

Vaata

eesti (ET) (460.88 KB - PDF)

Vaata

ελληνικά (EL) (957.24 KB - PDF)

Vaata

français (FR) (383.63 KB - PDF)

Vaata

hrvatski (HR) (504.46 KB - PDF)

Vaata

italiano (IT) (614.01 KB - PDF)

Vaata

latviešu (LV) (750.12 KB - PDF)

Vaata

lietuvių (LT) (673.01 KB - PDF)

Vaata

magyar (HU) (1.07 MB - PDF)

Vaata

Malti (MT) (774.79 KB - PDF)

Vaata

Nederlands (NL) (445.92 KB - PDF)

Vaata

polski (PL) (1.09 MB - PDF)

Vaata

português (PT) (456.69 KB - PDF)

Vaata

română (RO) (807.04 KB - PDF)

Vaata

slovenčina (SK) (711.68 KB - PDF)

Vaata

slovenščina (SL) (702.28 KB - PDF)

Vaata

suomi (FI) (456.54 KB - PDF)

Vaata

svenska (SV) (441.7 KB - PDF)

Vaata

Íslenska (IS) (622.5 KB - PDF)

Vaata

norsk (NO) (656.3 KB - PDF)

Vaata
Latest procedure affecting product information:IAIN/0014
31/10/2012

български (BG) (299.51 KB - PDF)

Vaata

español (ES) (219.22 KB - PDF)

Vaata

čeština (CS) (262.67 KB - PDF)

Vaata

dansk (DA) (227.42 KB - PDF)

Vaata

Deutsch (DE) (218.75 KB - PDF)

Vaata

eesti (ET) (221.16 KB - PDF)

Vaata

ελληνικά (EL) (268.37 KB - PDF)

Vaata

français (FR) (221.14 KB - PDF)

Vaata

hrvatski (HR) (227.55 KB - PDF)

Vaata

italiano (IT) (191.92 KB - PDF)

Vaata

latviešu (LV) (256.74 KB - PDF)

Vaata

lietuvių (LT) (210.34 KB - PDF)

Vaata

magyar (HU) (210.45 KB - PDF)

Vaata

Malti (MT) (250.85 KB - PDF)

Vaata

Nederlands (NL) (228.06 KB - PDF)

Vaata

polski (PL) (245.92 KB - PDF)

Vaata

português (PT) (231.37 KB - PDF)

Vaata

română (RO) (434.62 KB - PDF)

Vaata

slovenčina (SK) (253.67 KB - PDF)

Vaata

slovenščina (SL) (237.31 KB - PDF)

Vaata

suomi (FI) (204.11 KB - PDF)

Vaata

svenska (SV) (218.51 KB - PDF)

Vaata

Íslenska (IS) (185.95 KB - PDF)

Vaata

norsk (NO) (222.67 KB - PDF)

Vaata

Product details

Name of medicine
Spironolactone Ceva
Active substance
spironolactone
International non-proprietary name (INN) or common name
spironolactone
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QC03DA01

Pharmacotherapeutic group

Diuretics

Therapeutic indication

For use in combination with standard therapy (including diuretic support, where necessary) for the treatment of congestive heart failure caused by valvular regurgitation in dogs.

Authorisation details

EMA product number
EMEA/V/C/000105
Marketing authorisation holder
Ceva Santé Animale

10 avenue de la Ballastière
33500 Libourne
France

Opinion adopted
17/04/2007
Marketing authorisation issued
20/06/2007
Revision
7

Assessment history

This page was last updated on

Share this page